Evidence-Based Complementary and Alternative Medicine

Therapies of Traditional Chinese Medicine for Cardiovascular Diseases 2021


Publishing date
01 Mar 2022
Status
Closed
Submission deadline
05 Nov 2021

Lead Editor

1North China University of Science and Technology, Tangshan, China

2Beijing University of Chinese Medicine, Beijing, China

3Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

4Hong Kong Polytechnic University, Hong Kong

5Mayo Clinic, Rochester, USA

This issue is now closed for submissions.

Therapies of Traditional Chinese Medicine for Cardiovascular Diseases 2021

This issue is now closed for submissions.

Description

Cardiovascular diseases (CVDs), including coronary heart disease, cerebrovascular disease, and heart failure, are the leading causes of death worldwide. In 2016, an estimated 17.9 million people died from CVDs, accounting for 31% of all global deaths. Recent reports on CVDs in China indicate that the prevalence and mortality of CVDs are still on the rise. The estimated number of people suffering from CVDs in China alone is 290 million, and the death rate of CVDs still ranks as first, accounting for more than 40% of deaths across the population. In recent years, the death rate of CVDs in rural areas has been shown to be higher than that in urban areas. The total cost of hospitalization for CVDs is also increasing rapidly, with the annual growth rate much higher than the GDP growth rate. The increasing burden of CVDs has become a major public health problem, and as such there is an urgent need to prevent and treat CVDs.

Although some recent reviews have suggested that Traditional Chinese Medicine (TCM) may benefit some heart disease patients and TCM treatment of diseases has indeed been recognized by patients, there is a lack of evidence-based research in line with the requirements of modern medical science. The exact mechanisms of the actions of TCM also need to be explained by scientific data, and so expert attention is needed to support the clinical value and effectiveness of TCM in treating CVDs.

The aim of this Special Issue is to collate results from the following aspects including safety of TCM therapies, side effects, clinical trials, and practice, to enrich the current knowledge of the efficacy of TCM therapies in treating CVDs. We invite researchers to contribute original research articles as well as review articles that will assess the roles of TCM therapies for CVDs.

Potential topics include but are not limited to the following:

  • In vivo or in vitro study to explore the exact mechanism of TCM therapies for CVDs
  • Recent development in TCM therapies for CVDs
  • Randomized clinical trials of TCM therapies for CVDs
  • Systematic review and/or meta-analysis of TCM therapies for CVDs
  • Toxicological effects associated with the use of TCM therapies for CVDs
  • Clinical practice of TCM therapies with conventional medicines and western medicine for CVDs
  • Perspective or commentary articles on TCM therapies for CVDs
  • Perspective or commentary articles on TCM therapies for CVDs and its complications

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 6265198
  • - Review Article

Acacetin as a Potential Protective Compound against Cardiovascular Diseases

Chunxuan Wu | Jianhua Yan | Wei Li
  • Special Issue
  • - Volume 2022
  • - Article ID 5804187
  • - Research Article

Traditional Chinese Medicine Shen-Yuan-Dan (SYD) Improves Hypoxia-Induced Cardiomyocyte Apoptosis in Neonatal Rats by Upregulating miR-24/Bim Pathway

Fuyong Chu | Xue Yan | ... | Hongxu Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 9024394
  • - Research Article

Mechanistic Insights of Qingre Jiedu Recipe Based on Network Pharmacology Approach against Heart Failure

Xuan Li | Mingyan Shao | ... | Chun Li
  • Special Issue
  • - Volume 2022
  • - Article ID 6181862
  • - Review Article

Current Status and Evaluation of Randomized Clinical Trials of Traditional Chinese Medicine in the Treatment of Cardiovascular Diseases

Xi Guo | Xiaojun Chen | ... | Hong Zhang
  • Special Issue
  • - Volume 2022
  • - Article ID 2152399
  • - Research Article

Pharmacological Mechanisms of Tinglizi against Chronic Heart Failure Determined by Network Pharmacology and Molecular Docking

Liangtao Luo | Haowen Wang | ... | Xing Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 1497722
  • - Review Article

Overview of Microvascular Angina Pectoris and Discussion of Traditional Chinese Medicine Intervention

Linghua Yu | Xiaoyan Lu | ... | Huangyu Xu
  • Special Issue
  • - Volume 2021
  • - Article ID 5779307
  • - Research Article

RNA-Seq Profiling to Investigate the Mechanism of Qishen Granules on Regulating Mitochondrial Energy Metabolism of Heart Failure in Rats

Hao He | Changxiang Li | ... | Chun Li
  • Special Issue
  • - Volume 2021
  • - Article ID 8443952
  • - Research Article

Samchulkunbi-Tang Alleviates Vascular Endothelial Disorder and Renal Dysfunction in Nitric Oxide-Deficient Hypertensive Rats

Mi Hyeon Hong | Jin Seok Hwang | ... | Ho Sub Lee
  • Special Issue
  • - Volume 2021
  • - Article ID 4854755
  • - Review Article

TCM Regulates PI3K/Akt Signal Pathway to Intervene Atherosclerotic Cardiovascular Disease

Jiali Liu | Pangao Xu | ... | Dan Zhang
  • Special Issue
  • - Volume 2021
  • - Article ID 2672516
  • - Review Article

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

Jingjing Wei | Shanshan Liu | ... | Mingjun Zhu
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.